Why are our leads not qualified?
For biotech and life sciences companies whose demand generation brings in names, not opportunities.
Marketing reports a record month for lead volume. Sales says the leads are junk. In biotech and life sciences, you're not just generating leads for one audience; you're speaking to investors, partners, and customers all at once. When your positioning is unclear, the campaigns pull in people who will never buy or invest.
The problem isn't your sales team. It's not the marketing team either. Unqualified leads happen when your message tries to speak to everyone at once. In biotech, you have three distinct audiences: investors, partners, and customers. Each needs its own page, its own version of the story. When you run one campaign for all of them, you get a lot of form fills from people who will never take a meeting. Your founder-scientist may write for peers, but investors and partners need translation without diluting the science. That gap is where leads break down.
Fixing this starts with positioning, not with more ads. The scope depends on how many audiences you serve and how clear your current message is. If you have separate pages for investors, partners, and customers already, the work is faster. If everything lives on one page, we need to build out the right architecture. The effort is in the strategy and the writing, not in chasing more traffic. It's a few weeks of focused work, not a year-long retainer.
This week, stop measuring marketing on lead volume. Start measuring on qualified opportunities. Look at your website: do investors, partners, and customers each have a clear path? If not, that's where you start. If you want help, call me. I'll look at your positioning and your demand generation with you, no pitch, no obligation. You don't get an account manager, you get me. Together we'll decide if SliiceXR is the right execution platform for the work.
When it's right, marketing and sales speak the same language. Every lead comes from someone who understands what you do and why it matters. Your website tells each audience a clear story. Investor materials match the site. And your pipeline is filled with real opportunities, not just names on a spreadsheet.
What our customers say
"Catherine has been a core part of LifeActive Bio for the past five years. From the beginning, I was impressed by her trustworthiness, creativity, discipline, and exceptional marketing expertise. She has brought strategic thinking and original ideas to our PR, marketing, campaign strategy, channel development, and client initiatives, with a unique ability to see challenges from multiple dimensions. Catherine is one of the most professional marketing visionaries I’ve encountered, and her creativity is beyond compare. Her passion for art is reflected in the originality she brings to everything she does. Catherine is an incredibly valued member of our team."
"Catherine is an extremely talented and creative designer and marketing professional. The projects we have worked on together have been productive, profitable and enjoyable. I would relish the opportunity to work with Catherine again."
"Catherine was instrumental in establishing our website. Of greater import, she greatly aided us in gaining market awareness and capitalizing on the market recognition we already had. Besides the website, Catherine hosted a weekly podcast wherein we shared our views and insights regarding significant developments in our industry and their short- and long-term implications for our business and our clients."
Other questions about demand generation for biotech and life sciences
demand generation vs lead generation
Lead generation collects contacts. Demand generation makes the right buyers want you before they fill anything out. Brand first, then demand, then the leads qualify themselves.
brand to demand
It means the brand does the pre-selling so demand programs cost less and convert better. I connect the two: position first, then campaigns that turn recognition into qualified opportunities.
Ready to talk?
Ask SliiceXR about demand generation for biotech and life sciences.